Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...

TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that Dr. Sina Bavari, Executive Vice President of Infe ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

Market is projected to grow at a CAGR of 5% through 2029, fueled by rising R&D costs, declining pharmaceutical sales, growing ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biotech company, announced its inclusion in the Russell 3000® and Russell 2000® Indexes fol ...

The leading Post-Traumatic Stress Disorder Companies such as Tonix Pharmaceuticals, Inc., Pop Test Oncology LLC, H. Lundbeck A/S, Bionomics Limited, Alto Neuroscience, Transcend Therapeutics and ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company, today ...

View the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKRAcquisition to be followed by merger; strengthens Torrent’s IPM market presence ...

Tonix Pharmaceuticals Holding Corp. detailed financials by Barron's. View TNXP business summary and company performance, for a clear financial breakdown.